| chlorthalidone / Generic mfg. |
DECONGEST, NCT05411991: Diuretic Treatment in Acute Heart Failure With Volume Overload Guided by Serial Spot Urine Sodium Assessment |
|
|
| Recruiting | 4 | 104 | Europe | UNa measurement after intravenous loop diuretic bolus, Intravenous acetazolamide 500 mg OD, Diamox (brand name for acetazolamide), Intravenous bumetanide TID, Burinex (brand name for bumetanide), Oral chlorthalidone OD, Hygroton (brand name for chlorthalidone), Intravenous canrenoate 200 mg OD, Soldactone (brand name for canrenoate), Maintenance infusion, Oral potassium supplements, KCl, Intravenous hypertonic saline, Switch to oral diuretic therapy, Usual AHF care | Vrije Universiteit Brussel, Roche Diagnostics, Jessa Hospital | Acute Heart Failure, Diuretics Drug Reactions | 03/24 | 04/24 | | |
NCT06041529: Study to Evaluate the Efficacy and Safety of TEL/AML/CTD in Elderly Patients With Essential Hypertension |
|
|
| Not yet recruiting | 4 | 250 | RoW | Telmisartan/Amlodipine/Chlorthalidone 40/5/12.5 mg, Truset 40/5/12.5mg, Telmisartan/Amlodipine/Hydrochlorothiazide 40/5/25 mg, Twynsta 40/5 mg, Dichlozid 25 mg | Yuhan Corporation | Essential Hypertension | 02/25 | 06/25 | | |
OPTION TREAT, NCT05920005: Candesartan Cilexetil + Chlorthalidone + Amlodipine Versus Exforge HCT®️ for Systemic Arterial Hypertension |
|
|
| Recruiting | 3 | 698 | RoW | candesartan cilexetil + chlorthalidone + amlodipine, Exforge HCT® (valsartan 160mg + hydrochlorothiazide 12.5mg + amlodipine 5mg) | Hospital Israelita Albert Einstein, Libbs Farmacêutica LTDA | Hypertension | 12/23 | 07/24 | | |
NCT02493322: Efficacy and Safety of Olmesartan Associated With Chlorthalidone in Essential Arterial Hypertension Control |
|
|
| Not yet recruiting | 3 | 261 | NA | Olmesartan Medoxomil 20mg + Chlorthalidone 12,5mg, Olmesartan medoxomil 20mg + Chlortalidone 25mg, Olmesartan 20mg + hydrochlorothiazide 12,5mg, Benicar HCT® | EMS | Essential Arterial Hypertension | 06/26 | 11/26 | | |
NCT02483936: Efficacy and Safety of Olmesartan Associated With Chlorthalidone Versus Benicar HCT® in Essential Hypertension Control |
|
|
| Not yet recruiting | 3 | 348 | NA | Olmesartan medoxomil 40mg + chlorthalidone 12,5mg, Olmesartan medoxomil 40mg + chlorthalidone 25mg, Olmesartan 40mg + Hydrochlorothiazide 12,5mg, Benicar HCT, Olmesartan 40mg + Hydrochlorothiazide 25mg | EMS | Arterial Hypertension | 06/25 | 09/26 | | |
NCT06282549: Study to Evaluate the Efficacy and Safety of TEL/AML/CTD in Elderly Patients With Essential Hypertension |
|
|
| Recruiting | N/A | 1210 | RoW | Telmisartan/Amlodipine/Chlorthalidone(Truset) | Yuhan Corporation | Essential Hypertension | 03/27 | 03/27 | | |
NCT04470830: A Study for PMS of AZL-M/CLD FDC in the Treatment of Participants With Essential HTN in South Korea |
|
|
| Completed | N/A | 718 | RoW | | Celltrion Pharm, Inc. | Essential Hypertension | 05/23 | 05/23 | | |